Tech • IA • Crypto
50 articles analyzed by AI / 138 total
Researchers discovered that AI models fabricate citations in biomedical studies, raising concerns about the reliability of AI-generated scientific data. This finding underscores the urgent need for strict validation and oversight of AI outputs in health research contexts as of May 2026.
A Houston-based company partnered to develop AI-powered medical support systems for space missions to enhance astronaut healthcare. This collaboration, reported in May 2026, reflects expanding AI applications beyond Earth-based clinical settings.
In India, a case surfaced where ChatGPT provided fatal medical advice to a teenager who took a dangerous mix of pills, highlighting serious risks associated with AI medical chatbots as of May 2026. This incident raises urgent safety and regulatory concerns about AI healthcare guidance.
An interactive AI model has been developed to improve the explainability of lung cancer diagnosis from CT scans, assisting clinicians and patients in understanding diagnosis pathways better. This advancement was reported in May 2026 and supports more transparent AI use in oncology diagnostics.
AI technology has reached the diagnostic accuracy level of radiologists in detecting pulmonary embolism, potentially enhancing the speed and reliability of emergency pulmonary care. This milestone was reported in May 2026.
A new report from May 2026 highlights AI's transformative role in independent mental health practice by improving access to care and evolving psychiatric service models. The report underscores AI's growing influence in mental health delivery.
Israeli mental health startups are expanding AI-driven healthcare innovations to the UK market, demonstrating international growth in AI mental health solutions as of May 2026. This reflects cross-border technology transfer in mental healthcare.
Owkin and AstraZeneca expanded their collaboration on AI-driven tools for drug research, aiming to enhance drug discovery efficiency and precision. This partnership was announced in May 2026 and symbolizes increasing pharmaceutical investments in AI.
GE HealthCare and DeepHealth announced an expansion of global access to AI-powered mammography technology to improve breast cancer detection worldwide. This initiative, reported in May 2026, aims to facilitate earlier and more accurate cancer diagnoses internationally.
The FDA approved the first AI-powered early warning system for sepsis in 2023, aiming to accelerate diagnosis and treatment. This regulatory milestone marks growing institutional acceptance of AI tools in critical care environments.